Press Release 16th April 2018
Boehringer Ingelheim and Lilly announce an academic collaboration with University of Oxford to investigate the effects of empagliflozin in people with chronic kidney disease.
Boehringer Ingelheim and Lilly announce an academic collaboration with University of Oxford
16 April 2018